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Children acquire HIV-1 infection through vertical transmission
occurring in utero, during the birth process, or postnatally
through breast-feeding.1 Other well-recognised routes include
contaminated blood products and sexual abuse.2,3
There are a number of reports from both First- and Third-
World settings of unusual HIV transmission.4-6 These include
nosocomial incidents where needles had been reused and
others where the cause was less obvious, but where access to a
‘sharps’ container was possible.  HIV infection in the
household was also documented.4-6
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Background. In the year 2000 we reported possible horizontal
transmission of HIV-1 infection between two siblings. An
investigation of three families, each with an HIV-infected
child but seronegative parents, permitted this finding. Sexual
abuse and surrogate breast-feeding were thought unlikely.
The children had overlapping hospitalisation in a regional
hospital. Since then several cases of unexplained HIV
infection in children have been reported. A registry was
established at Tygerberg Children’s Hospital for collection of
data on the extent of horizontal or unexplained transmission
of HIV in children. 
Study design. Retrospective chart review.
Results. Fourteen children were identified, 12 from the
Western Cape and 1 each from the Eastern Cape and
KwaZulu-Natal. Thirteen (92%) had been hospitalised
previously. In the Western Cape, children had been
hospitalised in 8 hospitals. Ten of 13 (77%) were admitted as
neonates and 9 of 13 (69%) had 2 or more admissions.
Intravascular cannulation and intravenous drug
administration occurred in all but 2 children before HIV
diagnosis. 
Conclusion. We have confirmed HIV infection in a number of
cases where the source of infection has been inadequately
explained. Circumstantial evidence supports but does not
prove nosocomial transmission. Further studies and
identification of medical procedures conducive to the spread
of HIV are urgently needed.
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In a recent epidemiological survey of HIV prevalence in
South Africa by the Human Sciences Research Council (HSRC),
86 HIV-positive children between 2 and 14 years of age were
identified, of whom 27 were matched to a biological parent. Of
20 parents tested, only 5 (4 mothers and 1 father) were HIV-
positive, suggesting by extrapolation that widespread
horizontal infection was possible.7
Background
In 1999 we were informed of 3 HIV-infected children with
seronegative parents from regional Hospital A. The possibility
of sexual abuse was excluded by an experienced child abuse
team. Through follow-up of the families we documented
circumstances supporting horizontal transmission from an
index case to his previously uninfected younger sibling.8 We
subsequently established a registry through publication in the
South African Medical Journal, requesting information on cases
of unexplained HIV-1 infection in children.9 The Institutional
Review Board of Stellenbosch University Faculty of Health
Sciences approved establishment of the registry.
Voluntary counselling and testing and vertical transmission
prophylaxis were introduced at Tygerberg Hospital in April
2002. Before this, infants were identified as HIV-exposed or
infected only if the mother or child had been tested on clinical
grounds or if a health care worker had sustained a needlestick
injury.10
The aim of the present study was to document the
circumstances around HIV-infected children with seronegative
parents brought to our attention. 
Methods
We conducted a retrospective study of children either from our
own institution, Tygerberg Children’s Hospital (TCH), or
reported from elsewhere. All available medical and nursing
notes were reviewed. An extensive history was taken from
parents and caregivers by at least 1 of the authors in all cases
from the Western Cape.  Note was taken of the circumstances
around the birth, especially identification of the infant at
delivery and of circumstances where either surrogate breast-
feeding or childhood sexual abuse (CSA) might have occurred.
All patients presenting to TCH, Hospital A and Red Cross
Children’s Hospital (RCCH) were examined by experienced
clinicians for anal or genital scarring and were referred to
social services departments for expert evaluation. 
Case definition
Our case definition for unusual infection was as follows: HIV
infection confirmed by demonstration of either HIV-1 RNA or
DNA by polymerase chain reaction (PCR) or p24 antigen by
enzyme immunosorbent assay (EIA) in infants below 18
months of age or antibodies to HIV-1 by EIA if above 18
months of age, on at least 2 occasions; under 10 years of age at
diagnosis; born to HIV-1 negative mothers or with previous
HIV-negative serology; and no clear evidence of sexual abuse
on history and examination. 
Results
Sixteen children were identified. Two females were excluded.
The first had a history of vaginal bleeding 4 years before
presentation and although sexual abuse had been excluded
through a social services investigation, we were unable to
verify the information. In the second case we became aware of
possible contact with an HIV-infected male from the same
household.
Except for 1 case from the Eastern Cape and another from
KwaZulu-Natal, all were from the Western Cape and were
managed by at least 1 of the authors.  Two investigators
conducted telephonic interviews with the mother of the child
reported from KwaZulu-Natal and with the paediatrician who
referred the case from the Eastern Cape. The paediatrician had
also submitted a written report, together with permission from
the parents permitting our access to data. 
A summary of clinical information is shown in Table I and
diagnostic evaluations in Table II. All 13 mothers (2 children
were siblings) were HIV-negative. In all cases where blood
products were given, the blood bank was contacted and donors
were re-tested confirming the absence of HIV infection. As at
least a few months had elapsed between the blood donation
and re-testing, the possibility of a blood donation during the
‘window’ period, before development of HIV-1 antibodies, was
unlikely. Maternity was confirmed by HLA genotyping in 5
cases. All mothers, and 2 caregivers, were asked about the
possibility of surrogate breast-feeding. Case 3 had possible
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Table I. Age, clinical and immunological classification in children
at time of diagnosis of unexplained HIV infection
Characteristic Number (N = 14)
Age at diagnosis  35 months (3 - 120 months)
(median (range))
CD4+ T-cell count (x 109/l) 909 (118 - 1 830)
(median (range))
CDC clinical stage
A 2
B 9
C 3
CDC immunological stage 
1 5
2 5
3 3
No CD4 T-cell count 1
CDC = Centers for Disease Control and Prevention.
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mucocutaneous contact with non-maternal breast- milk but
may have already been HIV-infected at the time. 
Case reports 
Cases 1 and 4
An infant (case 1) was born by normal delivery and was breast-
fed by his mother. He required admission to Hospital A for
meningitis at 3 years of age and again 6 months later for
cryptosporidial diarrhoea. HIV infection was diagnosed but
both parents and his 16-month-old sibling brother (case 4) were
HIV-negative.
Case 4 presented again at 31 months of age with severe
persistent otorrhoea. HIV was confirmed, while both parents
remained uninfected. 
The family was referred to TCH for evaluation. Phylogenetic
testing showed that the brothers were infected with the same
strain of virus, indicating horizontal transmission. The brothers
shared a bed. Infection probably occurred as a result of the
HIV-infected infant having epistaxis and chronic otorrhoea at
the time that his sibling had herpes stomatitis.8
Case 2 
An infant was hospitalised in Hospital A for a day after a home
birth. He was rehospitalised at 10 months of age with
disseminated tuberculosis (TB). Therapy was continued at
Hospital B, a TB sanatorium. At 15 months of age HIV-1 was
diagnosed at TCH because of chronic lung disease. 
Case 3
This infant was delivered by emergency caesarean section at 30
weeks’ gestation in Hospital A. The mother presented with
antepartum haemorrhage due to placenta praevia. He required
intravenous antibiotics and fluids and was fed with maternal
expressed breast-milk. At 5 months of age, expressed breast-
milk from the mother’s friend was placed in his ear as a
remedy for persistent otorrhoea. The donor was HIV-negative
during subsequent investigation. He was rehospitalised at 6
months of age for pneumonia, again needing intravenous
antibiotics. At 10 months of age HIV-1 infection was diagnosed. 
Case 5 
This male infant with fetal alcohol syndrome and posterior
urethral valves was born in Hospital C and transferred to TCH.
He required multiple surgical procedures and several blood
product transfusions. Multiple episodes of sepsis were
documented. At 8 months of age he tested negative for HIV-1
after a health care worker sustained a needlestick injury. At 26
months he was re-tested because of generalised lymphadeno-
pathy, failure to thrive and hilar adenopathy. HIV-1 antibodies
were detected. The health care worker involved in the
needlestick injury was re-tested and remained negative for
HIV-1. 
Case 6  
A male infant from the Eastern Cape born at 32 weeks’
gestation was hospitalised for the first 3 days of life. No
procedures were documented. At 19 months of age he
presented with severe pneumonia and a history of intermittent
diarrhoea at which time HIV infection was confirmed.
Case 7 
A male infant born at 31 weeks’ gestation was cared for at TCH
and in a ‘step-down’ nursery in Hospital C. He developed
rotavirus diarrhoea, necrotising enterocolitis (managed
medically), several episodes of sepsis and had multiple blood
transfusions. He required a central line for intravenous access.
This infant had two negative HIV-1 EIAs during the first
month of life, one because the mother had a positive rapid
plasma reagin (RPR) test, and a second after a needlestick
injury to a health care worker. At 3 months of age he required
readmission to TCH because of viral pneumonia. He was re-
tested for HIV after a needlestick injury to a health care worker
and had HIV antibodies. The health care worker involved in
the first needlestick injury was HIV-uninfected. 
Case 8
A male infant born at 32 weeks’ gestation in Hospital D was
hospitalised for 2 weeks. He required readmission several
times from 5 months of age for pneumonia and gastroenteritis.
He also had severe upper airway obstruction due to enlarged
adenoids.  He was transferred to TCH intensive care unit after
intubation for severe upper-airway obstruction. Antibodies to
HIV-1 were detected. 
Case 9
A 9-year-old girl was admitted to TCH with a pleural effusion.
Table II. Diagnostic HIV investigations for 14 children with
unexplained HIV-1 infection and their contacts
Individuals tested Assay (result) Results Number 
Cases tested before 
HIV diagnosis EIA Negative 4 
Cases at diagnosis EIA All positive 14 
PCR All positive 11 
Mothers EIA All negative 13* 
PCR All negative 7 
Fathers EIA (all negative) All negative 10
PCR (negative) Negative 1 
Siblings EIA/PCR 5 negative 6
1 positive (case 1)
Caregivers EIA Negative 2 
Blood donors Blood transfusion Negative 4
services
*Two cases were siblings.
EIA = enzyme immunosorbent assay; PCR = polymerase chain reaction.
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TB was diagnosed after a diagnostic thoracocentesis. She was
transferred to Hospital C for 3 weeks. She presented 1 year
later with a mild gastrointestinal upset. She tested positive for
HIV after a needlestick injury to a health care worker. 
Case 10
A term infant from KwaZulu-Natal was ventilated for 1 day
because of respiratory distress. In the year preceding diagnosis
of HIV-1 infection, she had repeated hospitalisations for
impetigo, pneumonia and tonsillitis. Antibodies to HIV-1 were
detected at 6 years of age. 
Case 11
At 3 years of age this girl was admitted to Hospital E with TB
meningitis. She received intravenous antibiotics and was
negative for HIV-1 (history from the mother).  Three years later
she had a tonsillectomy at Hospital C. At 8 years of age she
presented to TCH with generalised lymphadenopathy and had
antibodies to HIV-1. 
Case 12
This baby was born at term by vaginal delivery. On day 2 of
life she was admitted to RCCH with haematocolpos requiring
surgical intervention. At 3 months of age she was readmitted
with severe pneumonia. HIV infection was diagnosed.11
Case 13
This term male infant was admitted to RCCH with prune-belly
syndrome shortly after a normal vaginal delivery. He was
readmitted at the age of 4 weeks with pneumonia. At 6 months
he presented with pneumonia and hepatosplenomegaly. HIV
infection was diagnosed.11
Case 14
A set of twins was born by vaginal delivery at TCH. At the age
of 1 month, twin A was admitted to RCCH with gastroenteritis
and presumed sepsis. His mother was tested for HIV infection
and was negative. He was discharged after 41 days, but
readmitted at the age of 4 months with hepatosplenomegaly
and pneumonia. TB was diagnosed and he was referred to a
community clinic for treatment. At the age of 7.5 months he
was readmitted to RCCH with pneumococcal meningitis, at
which time HIV infection was diagnosed.
Possible transmission in health care facilities 
Hospitalisation preceded the diagnosis of HIV-1 infection in 13
of 14 cases. Hospitals included several regional and two
tertiary institutions in the Western Cape. Both cases outside of
the Western Cape were from the private sector. Possible risk
factors for nosocomial transmission are summarised in Table
III. 
Outcome
Four patients died and 1 was lost to follow-up. Three patients
do not yet require antiretroviral therapy and the rest are
receiving triple therapy. Two of these have severe end-organ
disease, 1 with chronic lung disease and the other with spastic
quadriplegia.
Discussion
We have documented a number of cases of HIV infection in
which the means of transmission was not clear. Any study of
this nature faces the serious difficulty of establishing possible
events and transmission risks of HIV, which occurred a long
time before diagnosis of HIV, especially in a health facility. This
study is an attempt to make sense of these incomplete data, to
encourage further research and to make suggestions to
decrease the risks in children admitted to hospital. 
Maternity was confirmed through linkage analysis in 5
patients.  CSA is extremely difficult to exclude.  Perineal lesions
associated with CSA may not be evident after a few months
and occasionally even after a few days in approximately half of
all cases. Many medical procedures such as haemoglobin and
blood glucose monitoring at birth and routine childhood
immunisation are poorly documented. 
During the neonatal period and early infancy there is also a
risk of giving HIV-infected expressed breast-milk. There is no
record that the donor of expressed breast-milk correlated with
the recipient. The amount of HIV in breast-milk is comparable
to that in plasma and the virus remains stable at room
temperature for at least 16 hours.12 That some of the children
from our survey received expressed breast-milk in hospital
suggests an opportunity for inadvertently giving contaminated
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Table III. Admission data and possible risk factors for nosocomial
transmission of HIV in cases with documented hospitalisation
Admission data and Number 
possible risk factors (N = 13)
Single admission < 14 days 2
Single admission > 14 days 2
Two or more admissions 9
Neonatal admission 10
Intensive care unit admission 6
Blood transfusion 4
Intravenous access 12 
Scalp vein access 2
Intravenous antibiotics 12
Surgical procedures* 3
Possible expressed breast-milk 10
*Two urogenital procedures and 1 tonsillectomy.
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milk to an uninfected infant. Single or multi-user breast pumps
could become contaminated between use (Gert Kirsten,
Department of Paediatrics and Child Health, Stellenbosch
University — personal communication). As much care should
be taken with administration of expressed breast-milk as with
blood products to ensure correct identification of donor and
recipient. Guidelines for correct procedures for management of
expressed breast-milk and care of breast pumps were
implemented in 2002.13,14 Surrogate breast-feeding is also not
easy to exclude as one relies entirely on the history of the
caregiver.
We have no knowledge of the HIV status of health care
workers who cared for the patients, but although HIV
transmission to patients is probably unlikely it has occasionally
been reported.15 Also, we did not document other possible risks
such as dental procedures, scarification and body piercing.16-18
In the majority of these children, nosocomial transmission of
HIV is a possibility. Brody et al.19 and Gisselquist and
colleagues20 presented epidemiological evidence linking the
spread of HIV infection in Africa to medical procedures.
Reports have linked the spread of the Ebola virus with re-use
of needles and syringes in underresourced African hospitals.21
To the best of our knowledge, needles and syringes are not
re-used in South Africa. We have, however, witnessed the re-
use of razor blades after brief immersion in chlorhexidine
(Hibitane) solution for shaving infants’ scalps before inserting
intravenous cannulae. When a medication is administered
intravenously to more than 1 patient a single syringe might be
used, especially in the setting of a heavy workload and
budgetary constraints. Intravascular lines are flushed with
heparinised saline from multi-use vials after infusion of
medication or withdrawal of blood. Health care workers could
re-use syringes after attaching a new sterile needle when
withdrawing saline, thus potentially contaminating the multi-
use vial. One investigator witnessed such an incident, which
has also been reported elsewhere in stressful situations.22 HIV-1
adheres to erythrocytes, which are far more numerous than
CD4+ T cells, thus increasing the range of cells that could
transmit HIV.23
We have observed that clinical notes can become
bloodstained after the leakage of blood from open-ended
capillary tubes. Occasionally, patient linen is bloodstained.
Although transmission through this route is unlikely, it reflects
a failure to appreciate the seriousness of exposure to blood.
HIV-1 decays slowly in whole blood and complete decay of
infectivity in plasma may take up to 7 days.24,25
It is also possible that a re-usable device for percutaneous
administration of bacille-Calmette-Guérin (BCG) vaccine may
have inadvertently contributed to the spread of HIV. BCG is
routinely administered to neonates within 1 - 2 days of birth.
Before 1996, a re-usable tool was used for percutaneous
administration. This device had strict guidelines for
sterilisation between usage, either by autoclaving or immersing
in gluteraldehyde.26 This instrument was replaced by a
disposable tool in 1996, and by intradermal injection with
disposable syringes in 2000. While there is no evidence that
sterilisation practices were not strictly adhered to, the re-usable
tool created a risk of abuse, especially if there were insufficient
tools available on a particular day. Even after the phasing out
of the re-usable instrument, 1 of the authors noted their
presence in some immunisation facilities (Neil Cameron —
personal observation).
Equipment such as endoscopes may be re-used after
sterilisation with gluteraldehyde.27 Although the sterilisation
process should be monitored regularly, this is often not done 
(S Mehtar — personal communication).  The mechanical
cleaning of equipment before autoclaving or cold sterilisation is
also important for adequate sterilisation, but is often
inadequately performed. Mucus and blood has been found in
ventilator tubing, threads of catheter mounts and inside face
masks (S Mehtar — personal communication). While anecdotal
observations may be difficult to link with infection, they reflect
the lack of expertise in this field.  Even 70% ethanol, a
commonly used disinfectant, has impaired ability to sterilise
when applied to inadequately cleaned surfaces.28
The risk of transmission of HIV-1 to household contacts is
estimated to be 0.2 - 0.7 infections per 100 years of contact.29 In
the only epidemiological investigation of horizontal
transmission in Africa, Mann et al.30 compared household
contacts of recently hospitalised HIV-infected subjects with
contacts from an orthopaedic ward in Kinshasa, Zaire.  In the
former, HIV-1 infection was present in 4.8% of non-spouse
household contacts versus 1.6% in control households.
Although not considered to support household spread, a
reappraisal suggested that household spread was possible.29
The risk, although small, increases if there is more than 1 HIV-
infected person in a household and could be exacerbated by
overcrowding and lack of indoor piped water. These conditions
are more likely in African settings than in developed countries. 
Conclusions
We have documented a number of cases of unexplained HIV
infection in children, many of which may have been
nosocomial. Although we cannot prove this, we feel that there
is sufficient evidence to investigate this possibility.
Epidemiological studies are necessary to document the extent
of unexplained HIV infection in children in resource-poor
settings. 
There is an urgent need to re-evaluate and improve infection
control practices in health care settings. Procedures for safe
administration of expressed breast-milk should be widely
disseminated. Infection control should receive high priority for
ORIGINAL ARTICLES
adequate funding so that personnel are continually trained and
procedures regularly monitored. 
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permission for publication. We thank the families for their
commitment and assistance in preparing this report.
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